Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 16 of 16 for “"galactosylceramide"”.

  1. Regulation of Galactosylceramide Biosynthesis

    … glycosylated to glucosylceramide (GlcCer) versus galactosylceramide (GalCer), which are precursors of all mammalian glycosphingolipids. Relatively few studies have focused on this branchpoint because these monohexosylceramides are somewhat difficult to resolve chromatographically and because …

    gatech Repository record for Regulation of Galactosylceramide Biosynthesis (opens in a new tab)

  2. Characterization of Alpha-Galactosylceramide As A Mucosal Adjuvant

    … effectiveness of a synthetic glycolipid, alpha-Galactosylceramide (-GalCer), as an adjuvant for mucosal immunization with peptide and protein antigens, by oral and intranasal routes, to prime antigen-specific immune responses in multiple systemic and mucosal compartments. The adjuvant activity …

    uthsc Repository record for Characterization of Alpha-Galactosylceramide As A Mucosal Adjuvant (opens in a new tab)

  3. The Influence of Immunization Route On The Adjuvant Effect of Alpha-Galactosylceramide

    … immunity. The synthetic glycolipid alpha-Galactosylceramide (α-GalCer) effectively activates the innate immune mediating NKT cells to produce cytokines and activate downstream immune cells, resulting in development of humoral and cell mediated immune responses to co-administered antigens. …

    uthsc Repository record for The Influence of Immunization Route On The Adjuvant Effect of Alpha-Galactosylceramide (opens in a new tab)

  4. Uncovering Novel Mechanism of Immune Modulation of Invariant Natural Killer T Cells By Liposomal Α-Galactosylceramide

    … sponge, <em>Agelas mauritianus</em>, alpha-Galactosylceramide (α-GalCer) potently activates iNK-T cells. Within a few hours after activation, iNK-T cells produce high quantities of T<sub>H</sub>1 and T<sub>H</sub>2 type cytokines, thus shape subsequent adaptive immunity towards inflammation …

    uthsc Repository record for Uncovering Novel Mechanism of Immune Modulation of Invariant Natural Killer T Cells By Liposomal Α-Galactosylceramide (opens in a new tab)

  5. Characterisation of the immunomodulatory properties of human natural killer T cells

    … when stimulated with the iNKT cell agonist α-galactosylceramide (αGalCer) in murine models. However iNKT cell based immunotherapies have proved disappointing in phase I and II clinical trials to date. Humans have a wider repertoire of CD1-restricted T cells compared to mice. These CD1 …

    maynooth Repository record for Characterisation of the immunomodulatory properties of human natural killer T cells (opens in a new tab)

  6. Structural and Functional Studies of the Human Saposin Proteins

    … the effective substrate-presenting particles in galactosylceramide hydrolysis. Finally, I compare the lipid interaction properties of the four saposins and address membrane perturbation, liposome binding, lipid solubilization and lipoprotein particle formation for each protein. Each saposin …

    toronto-retro Repository record for Structural and Functional Studies of the Human Saposin Proteins (opens in a new tab)

  7. Structure-Activity Studies of Glycosphingolipids as Antigens of Natural Killer T Cells

    … These include fluorophore-appended 6”-amino-α-galactosylceramides and N-alkenoyl GSLs, such as PBS-57, a potent alphaGalCer surrogate useful in NKT cell stimulation studies. A nonantigenic beta-C-galactosylceramide has also been prepared as an inhibitor of these innate lymphocytes. To probe the …

    byu Repository record for Structure-Activity Studies of Glycosphingolipids as Antigens of Natural Killer T Cells (opens in a new tab)

  8. Lipid-coated micro- and nanoparticles as a biomimetic vaccine delivery platform

    … of 2 ng antigen co-displayed on particles with c-galactosylceramide elicited measurable titers, and a prime-boost regimen of 2.5 ng ovaparticles adjuvanted with monophosphoryl lipid A elicited high titers that were sustained for >150 days. No studies to our knowledge have reported dose sparing to …

    mit Repository record for Lipid-coated micro- and nanoparticles as a biomimetic vaccine delivery platform (opens in a new tab)

  9. Lipid antigens and immunoregulatory iNKT cells in the prevention and treatment of type 1 diabetes and related autoimmune diseases

    … and presentation of lipid antigens such as α-galactosylceramide (α-GalCer) to iNKT cells, producing a variety of anti-inflammatory (T\(_H\)2) cytokines, such as interleukin-4 (IL-4), and pro-inflammatory (T\(_H\)1) cytokines, such as interferon-γ (IFN-γ). A decreased number of iNKT cells and …

    birmingham Repository record for Lipid antigens and immunoregulatory iNKT cells in the prevention and treatment of type 1 diabetes and related autoimmune diseases (opens in a new tab)

  10. The Role of Specific Integrase Strand Transfer Inhibitors (INSTIs) in the Alteration of Oligodendrocyte Maturation and Myelination in Hand

    … positive for immature oligodendrocyte marker galactosylceramide (GalC) and mature oligodendrocyte marker myelin basic protein (MBP) in vitro, as well as the synthesis of myelin proteins. However, neither EVG or RAL induced cell loss or apoptosis, as determined by cell counts and TUNEL assays, …

    penn Repository record for The Role of Specific Integrase Strand Transfer Inhibitors (INSTIs) in the Alteration of Oligodendrocyte Maturation and Myelination in Hand (opens in a new tab)

  11. Protein-sphingolipid interactions and their role in immunity and disease

    … proteins. I next asked whether AC processes galactosylceramide to psychosine, the cytotoxic GALC substrate accumulating in Krabbe disease, contributing to Krabbe disease pathology by increasing oligodendrocyte cell death. Surprisingly, I found that GALC knockout oligodendrocytes were not more …

    cambridge Repository record for Protein-sphingolipid interactions and their role in immunity and disease (opens in a new tab)

  12. Structural analysis of glycolipid-derived oligosaccharides from metabolically radiolabelled colorectal carcinoma SW1116 cells

    … fraction were, glucosylceramide (Glc-Cer), galactosylceramide(Gal-Cer), galabiosylceramide (Galαl-4Gal-Cer), lacto-N-tetraosylceramide (Galβ1-3GIcNAcβ1-3Galβ1-4Glc-Cer), Le<sup>a</sup>- pentaglycosylceramide (Galβ1-3[Fucal-4]GlcNAcβ1-3Galβ1-4Glc-Cer), HIpentaglycosylceramide …

    vt Repository record for Structural analysis of glycolipid-derived oligosaccharides from metabolically radiolabelled colorectal carcinoma SW1116 cells (opens in a new tab)

  13. The Role Of Inflammation In Pathogenesis And Treatment Of Globoid-Cell Leukodystrophy

    … in altered catabolism of the myelin lipid Galactosylceramide. The disease predominantly affects the white matter of the CNS and the myelin sheath of the peripheral nerves. The infantile form of the disease is characterized by early onset between 3-6 months of age with symptoms of …

    wustl Repository record for The Role Of Inflammation In Pathogenesis And Treatment Of Globoid-Cell Leukodystrophy (opens in a new tab)

  14. LIPID COMPOSITION OF MICROGLIAL CELLS AND EFFECTS OF A REMYELINATION-PROMOTING ANTIBODY ON THE SPHINGOLIPID PATTERNS

    … the absence of specific lipids, including galactosylceramide and sulfatide, and a generally low amount of gangliosides in both sub-populations, irrespective of confluence. Then, we studied the sphingolipid turnover in more detail using a metabolic labeling approach. Our results showed that …

    milano Repository record for LIPID COMPOSITION OF MICROGLIAL CELLS AND EFFECTS OF A REMYELINATION-PROMOTING ANTIBODY ON THE SPHINGOLIPID PATTERNS (opens in a new tab)

  15. Intranasal Hpv Peptide Vaccine Formulation Induces Potent Cytotoxic Cd8 T Cell Immunity For The Treatment of Genital Hpv Tumors

    <p>Human Papillomavirus (HPV) induced cancers continue to affect millions of women worldwide, with the five year survival rate hovering just under 60% in some demographics. Therefore there is an unmet need to develop effective, yet, easily administered therapies to treat established HPV genital …

    uthsc Repository record for Intranasal Hpv Peptide Vaccine Formulation Induces Potent Cytotoxic Cd8 T Cell Immunity For The Treatment of Genital Hpv Tumors (opens in a new tab)